Molecular mechanisms illustrated that compound 12a could induce morphological changes and affect the expression levels of apoptosis-related proteins (Bcl-2 and Cleaved-parp) against prostate cancer cells. This evidence concerns the gene BCL2 and prostate carcinoma.